Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Day One Biopharmaceuticals (DAWN) Accumulated Depreciation & Amortization (2022 - 2023)

Historic Accumulated Depreciation & Amortization for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q3 2023 value amounting to $30000.0.

  • Day One Biopharmaceuticals' Accumulated Depreciation & Amortization fell 6385.54% to $30000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $30000.0, marking a year-over-year decrease of 6385.54%. This contributed to the annual value of $6000.0 for FY2022, which is N/A changed from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Accumulated Depreciation & Amortization stood at $30000.0 for Q3 2023, which was down 6385.54% from $18000.0 recorded in Q2 2023.
  • Day One Biopharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $83000.0 for Q3 2022, and its period low was $6000.0 during Q4 2022.